RBM45 activators are a class of chemicals that can enhance the function of the RNA-binding protein RBM45. These chemicals impact various signaling pathways or cellular processes that RBM45 is involved in, thereby influencing its activity. For instance, Anisomycin, a protein synthesis inhibitor, triggers the JNK and p38 MAPK pathways, which RBM45 is associated with, leading to enhanced functionality of RBM45.
Forskolin, an activator of adenylate cyclase, increases the level of cAMP, regulating several physiological responses. Given that RBM45 is implicated in cAMP-dependent signaling pathways, Forskolin enhances RBM45 function. Furthermore, Resveratrol, a natural polyphenol, activates Sirtuin 1, an enzyme associated with cellular stress response, enhancing RBM45 function. Genistein, a tyrosine kinase inhibitor, can influence the PI3K/Akt pathway, where RBM45 operates, thereby enhancing RBM45 functionality. Staurosporine, a potent protein kinase inhibitor, enhances RBM45 by modifying protein kinase signaling. Trichostatin A, a histone deacetylaseinhibitor, also has a role in enhancing RBM45 by altering histone acetylation state, which subsequently affects gene expression. PD98059, a MEK inhibitor upstream of ERK in the MAPK pathway, is another chemical that enhances RBM45 function. Additionally, Y-27632, a selective inhibitor of Rho-associated protein kinases (ROCKs), influences RBM45's function within protein kinase signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates the JNK and p38 MAPK pathways. RBM45 is implicated in these pathways, hence anisomycin can enhance the function of RBM45 by activating the MAPK pathway. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, which increases cAMP levels. Since RBM45 is involved in cAMP-dependent signaling pathways, forskolin can enhance RBM45 function by increasing cAMP levels. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates Sirtuin 1, an enzyme involved in cellular stress response. Since RBM45 is involved in stress response, resveratrol can enhance RBM45 function by activating Sirtuin 1. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that influences the PI3K/Akt pathway. RBM45 is involved in this pathway, so genistein enhances RBM45 function by inhibiting tyrosine kinase. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Given that RBM45 operates within protein kinase signaling, staurosporine can enhance RBM45 function by altering this signaling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that alters histone acetylation state, influencing downstream gene expression. RBM45 function is enhanced when histone acetylation state is altered by Trichostatin A. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, a kinase upstream of ERK in the MAPK pathway. RBM45 operates within this pathway, so PD98059 enhances RBM45 function by inhibiting MEK. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of Rho-associated protein kinases (ROCKs). Given that RBM45 operates within protein kinase signaling, Y-27632 enhances RBM45 function by altering this signaling. | ||||||